1,25(OH)2 vitamin D3, and retinoic acid antagonize endothelin-stimulated hypertrophy of neonatal rat cardiac myocytes.
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
1,25(OH)2 Vitamin D3 (VD3) and retinoic acid (RA) function as ligands for nuclear receptors which regulate transcription. Though the cardiovascular system is not thought to represent a classical target for these ligands, it is clear that both cardiac myocytes and vascular smooth muscle cells respond to these agents with changes in growth characteristics and gene expression. In this study we demonstrate that each of these ligands suppresses many of the phenotypic correlates of endothelin-induced hypertrophy in a cultured neonatal rat cardiac ventriculocyte model. Each of these agents reduced endothelin-stimulated ANP secretion in a dose-dependent fashion and the two in combination proved to be more effective than either agent used alone (VD3: 49%; RA:52%; VD3 + RA:80% inhibition). RA, at concentrations known to activate the retinoid X receptor, and, to a lesser extent, VD3 effected a reduction in atrial natriuretic peptide, brain natriuretic peptide, and alpha-skeletal actin mRNA levels. Similar inhibition (VD3:30%; RA:33%; VD3 + RA:59% inhibition) was demonstrated when cells transfected with reporter constructs harboring the relevant promoter sequences were treated with VD3 and/or RA for 48 h. These effects were not accompanied by alterations in endothelin-induced c-fos, c-jun, or c-myc gene expression, suggesting either that the inhibitory locus responsible for the reduction in the mRNA levels lies distal to the activation of the immediate early gene response or that the two are not mechanistically coupled. Both VD3 and RA also reduced [3H]leucine incorporation (VD3:30%; RA:33%; VD3 + RA:45% inhibition) in endothelin-stimulated ventriculocytes and, once again, the combination of the two was more effective than either agent used in isolation. Finally, 1,25(OH)2 vitamin D3 abrogated the increase in cell size seen after endothelin treatment. These findings suggest that the liganded vitamin D and retinoid receptors are capable of modulating the hypertrophic process in vitro and that agents acting through these or similar signaling pathways may be of value in probing the molecular mechanisms underlying hypertrophy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J., & Rutter, W. J. (1979) · Biochemistry · doi:10.1021/bi00591a005 · Cited by 21,725
Effects of cytochalasin and phalloidin on actin.
Cooper, J. A. (1987) · The Journal of cell biology · doi:10.1083/jcb.105.4.1473 · Cited by 2,009
Identification of a receptor for the morphogen retinoic acid
Giguere, V., Ong, E. S., Segui, P., & Evans, R. M. (1987) · Nature · doi:10.1038/330624a0 · Cited by 1,965
Umesono, K., Murakami, K. K., Thompson, C. C., & Evans, R. M. (1991) · Cell · doi:10.1016/0092-8674(91)90020-y · Cited by 1,716
Sadoshima, J., & Izumo, S. (1993) · Circulation Research · doi:10.1161/01.res.73.3.413 · Cited by 1,427
Yu, V. C., Delsert, C., Andersen, B., Holloway, J. M., Devary, O. V., Näär, A. M., Kim, S. Y., Boutin, J.-M., Glass, C. K., & Rosenfeld, M. G. (1991) · Cell · doi:10.1016/0092-8674(91)90301-e · Cited by 1,205
Mendelsohn, C., Lohnes, D., Décimo, D., Lufkin, T., LeMeur, M., Chambon, P., & Mark, M. (1994) · Development · doi:10.1242/dev.120.10.2749 · Cited by 992
Cloning and expression of full-length cDNA encoding human vitamin D receptor.
Baker, A. R., McDonnell, D. P., Hughes, M., Crisp, T. M., Mangelsdorf, D. J., Haussler, M. R., Pike, J. W., Shine, J., & O'Malley, B. W. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.10.3294 · Cited by 959
Chien, K. R., Knowlton, K. U., Zhu, G., & Chien, S. (1991) · The FASEB Journal · doi:10.1096/fasebj.5.15.1835945 · Cited by 794
A novel rapid assay for chloramphenicol acetyltransferase gene expression
Neumann, J., Morency, C. A., & Russian, K. O. (1987) · BioTechniques · Cited by 749
Cited by
The Nuclear Vitamin D Receptor: Biological and Molecular Regulatory Properties Revealed
Haussler, M. R., Whitfield, G. K., Haussler, C. A., Hsieh, J.-C., Thompson, P. D., Selznick, S. H., Dominguez, C. E., & Jurutka, P. W. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.3.325 · Cited by 1,421
Dusso, A. S., Brown, A. J., & Slatopolsky, E. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00336.2004 · Cited by 1,148
Pilz, S., März, W., Wellnitz, B., Seelhorst, U., Fahrleitner-Pammer, A., Dimai, H. P., Boehm, B. O., & Dobnig, H. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0784 · Cited by 607
Xiang, W., Kong, J., Chen, S., Cao, L.-P., Qiao, G., Zheng, W., Liu, W., Li, X., Gardner, D. G., & Li, Y. C. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00224.2004 · Cited by 570
Self-citationThadhani, R., Appelbaum, E., Pritchett, Y., Chang, Y., Wenger, J., Tamez, H., Bhan, I., Agarwal, R., Zoccali, C., Wanner, C., et al. (2012) · JAMA · doi:10.1001/jama.2012.120 · Cited by 567
Vitamin A metabolism: An update
D’Ambrosio, D. N., Clugston, R. D., & Blaner, W. S. (2011) · Nutrients · doi:10.3390/nu3010063 · Cited by 562
“Experiments employing rat cardiomyocytes in vitro have shown that retinoic acid can attenuate cardiomyocyte hypertrophy induced by endothelin-1, phenylephrine, and angiotensin-II [175–178].”
BackgroundNuclear Receptor Signaling and Cardiac Energetics
Huss, J. M., & Kelly, D. P. (2004) · Circulation Research · doi:10.1161/01.res.0000141774.29937.e3 · Cited by 473
Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure
Rostand, S. G., & Drüeke, T. B. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00575.x · Cited by 419
Antiproteinuric effect of oral paricalcitol in chronic kidney disease
Agarwal, R., Acharya, M., Tian, J., Hippensteel, R. L., Melnick, J. Z., Qiu, P., Williams, L., & Batlle, D. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00755.x · Cited by 377
Shoji, T., Shinohara, K., Kimoto, E., Emoto, M., Tahara, H., Koyama, H., Inaba, M., Fukumoto, S., Ishimura, E., Miki, T., et al. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg513 · Cited by 351
Cardiomyocyte-Specific Deletion of the Vitamin D Receptor Gene Results in Cardiac Hypertrophy
Chen, S., Law, C. S., Grigsby, C. L., Olsen, K., Hong, T.-T., Zhang, Y., Yeghiazarians, Y., & Gardner, D. G. (2011) · Circulation · doi:10.1161/circulationaha.111.032680 · Cited by 343
Self-citationBodyak, N., Ayus, J. C., Achinger, S., Shivalingappa, V., Ke, Q., Chen, Y.-S., Rigor, D. L., Stillman, I., Tamez, H., Kroeger, P. E., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611202104 · Cited by 333
Vitamin D in chronic kidney disease: A systemic role for selective vitamin D receptor activation
Andress, D. L. (2006) · Kidney International · doi:10.1038/sj.ki.5000045 · Cited by 309
Vitamin D, cardiovascular disease and mortality: Vitamin D, CVD and mortality
Pilz, S., Tomaschitz, A., März, W., Drechsler, C., Ritz, E., Zittermann, A., Cavalier, E., Pieber, T. R., Lappe, J. M., Grant, W. B., et al. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04147.x · Cited by 260
Effect of Paricalcitol on Left Ventricular Mass and Function in CKD—The OPERA Trial
Wang, A. Y.-M., Fang, F., Chan, J., Wen, Y.-Y., Qing, S., Chan, I. H.-S., Lo, G., Lai, K.-N., Lo, W.-K., Lam, C. W.-K., et al. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013010103 · Cited by 255
Vitamin D and the Cardiovascular System
Artaza, J. N., Mehrotra, R., & Norris, K. C. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02260409 · Cited by 194
“Activated vitamin D has been shown to downregulate proliferation and hypertrophy in cultured cardiomyocytes (39,40).”
BackgroundExpression of the Vitamin D Receptor Is Increased in the Hypertrophic Heart
Chen, S., Glenn, D. J., Ni, W., Grigsby, C. L., Olsen, K., Nishimoto, M., Law, C. S., & Gardner, D. G. (2008) · Hypertension · doi:10.1161/hypertensionaha.108.119602 · Cited by 194
“The key findings of the present report are: (1) the demonstration of VDR in both cardiac myocytes and fibroblasts, as well as ventricular myocardium, using a combination of biochemical, immunofluorescence, and functional assays, (2) the demonstration of 1--hydroxylase in the same sources and 24-hydroxylase protein in…”
Self-citationExtraskeletal actions of vitamin D
Bikle, D. D. (2016) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13219 · Cited by 179
Levin, A., & Li, Y. C. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00651.x · Cited by 173
“Using a similar in vitro ventricular myocyte culture, Wu et al [51] found that 1,25-dihydroxyvitamin D3 inhibited myocyte hypertrophy induced by endothelin and the expression of askeletal actin and ANP gene, which were associated with myocardial hypertrophy and heart failure.”
MethodEvolving concepts in the pathogenesis of uraemic cardiomyopathy
Wang, X., & Shapiro, J. I. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0101-8 · Cited by 161
Deo, R., Katz, R., Shlipak, M. G., Sotoodehnia, N., Psaty, B. M., Sarnak, M. J., Fried, L. F., Chonchol, M., de Boer, I. H., Enquobahrie, D., et al. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.179135 · Cited by 107
Metadata
- Authors
- Wu, J., Garami, M., Cheng, T., & Gardner, D. G.
- Venue
- Journal of Clinical Investigation
- Published
- 1996-04-01
- Volume
- 97
- Issue
- 7
- Pages
- 1577-1588
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2003162718
- Cited by
- 257
- References
- 42
- FWCI
- 4.63
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.